KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Asset Writedowns and Impairment (2016 - 2026)

Medtronic (MDT) has disclosed Asset Writedowns and Impairment for 13 consecutive years, with $36.0 million as the latest value for Q1 2026.

  • Quarterly Asset Writedowns and Impairment fell 29.41% to $36.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $129.0 million through Jan 2026, down 68.15% year-over-year, with the annual reading at $123.0 million for FY2025, 66.85% down from the prior year.
  • Asset Writedowns and Impairment hit $36.0 million in Q1 2026 for Medtronic, down from $38.0 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $466.0 million in Q2 2022 to a low of -$466.0 million in Q1 2022.
  • Historically, Asset Writedowns and Impairment has averaged $39.4 million across 5 years, with a median of $26.0 million in 2022.
  • Biggest YoY gain for Asset Writedowns and Impairment was 1764.0% in 2022; the steepest drop was 552.43% in 2022.
  • Year by year, Asset Writedowns and Impairment stood at $26.0 million in 2022, then plummeted by 38.46% to $16.0 million in 2023, then skyrocketed by 68.75% to $27.0 million in 2024, then skyrocketed by 40.74% to $38.0 million in 2025, then decreased by 5.26% to $36.0 million in 2026.
  • Business Quant data shows Asset Writedowns and Impairment for MDT at $36.0 million in Q1 2026, $38.0 million in Q4 2025, and $28.0 million in Q3 2025.